Paroxysmal dystonia

Paroxysmal dystonia is a group of rare movement disorders characterized by episodic attacks of dystonic posturing and involuntary movements that occur intermittently, with normal neurological function between episodes. These conditions primarily affect the nervous system and musculoskeletal system, causing sudden, often disabling episodes of sustained muscle contractions that lead to abnormal postures and twisting movements of the limbs, trunk, and sometimes the face. The term encompasses several subtypes, including paroxysmal kinesigenic dyskinesia (PKD), paroxysmal nonkinesigenic dyskinesia (PNKD), and paroxysmal exercise-induced dyskinesia (PED), each distinguished by their specific triggers and duration of attacks. In paroxysmal kinesigenic dyskinesia, episodes are triggered by sudden voluntary movements and typically last seconds to minutes. In paroxysmal nonkinesigenic dyskinesia, attacks occur spontaneously or are triggered by stress, fatigue, caffeine, or alcohol, and may last minutes to hours. Paroxysmal exercise-induced dyskinesia is triggered by prolonged physical exertion, with episodes typically lasting 5 to 30 minutes. Between attacks, patients generally have a normal neurological examination, though the frequency and severity of episodes can significantly impact quality of life. Treatment varies by subtype. PKD often responds remarkably well to low doses of anticonvulsant medications, particularly carbamazepine or phenytoin. PNKD may respond to benzodiazepines such as clonazepam, and avoidance of known triggers is an important management strategy. PED may benefit from dietary modifications, particularly in cases associated with GLUT1 deficiency where a ketogenic diet can be effective. Genetic testing is increasingly important for diagnosis and guiding treatment, as several causative genes have been identified, including PRRT2 (for PKD), MR-1/PNKD gene (for PNKD), and SLC2A1 (for some cases of PED).

Common questions about Paroxysmal dystonia